CRISPR-HAWK is a guide-RNA design tool created by researchers from the University of Verona, Harvard Medical School, and the Broad Institute to account for real-world human genetic variation. Unlike typical CRISPR tools, which rely solely on a reference genome, it takes into account population and individual variants, as well as haplotypes, to predict how editing…
The ability to precisely alter genes with CRISPR technology has revolutionized biomedical research. It does, however, take a thorough grasp of CRISPR technology and sophisticated experimental setups to design effective gene-editing systems. Despite its promise in various tasks, large language models (LLMs) sometimes lack specialized expertise and have difficulty correctly answering biological design puzzles. Researchers…
CRISPR interference (CRISPRi) is one of the most widely used CRISPR technologies in bacteria. In this, a catalytically dead Cas protein incapable of DNA cleavage (dCas) is targeted to interfere with the transcription of a gene of choice. Due to complex interactions between guide sequences predicting it accurately remains a challenge. To tackle this problem,…
Cancer, a simple name for a complicated group of diseases, has long perplexed scientists and healthcare professionals alike. Despite years of research and medical advances, individualized therapy remains elusive. However, a recent study using multi-omics data is bringing us closer to understanding cancer’s weaknesses and maybe opening up new therapeutic options. By integrating diverse datasets…
While chromosomal synthesis and cloning are expensive and time-consuming processes, CReATiNG (Cloning, Reprogramming, and Assembling Tiled Natural Genomic DNA), a method introduced by researchers at the University of Southern California, presents a viable substitute. With this technique, sections of natural chromosomes are cloned and put together to create synthetic chromosomes. CReATiNG can change a cell’s…
The UK has achieved a historic milestone by becoming the first country to authorize a revolutionary new treatment for two serious inherited blood conditions – sickle cell disease and beta-thalassemia. The cutting-edge therapy utilizes CRISPR gene editing technology to precisely correct errors in patients’ blood stem cells, potentially curing them of debilitating symptoms. Announced earlier…
Through the advent of CRISPR-Cas12, scientists have managed to unlock a new world of gene editing and reprogramming, with important applications for diagnostics, therapeutics, agricultural science, and more. However, their bacterial origin may make them difficult to work with as researchers begin to explore the potential of human genome editing. A new study led by…
| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
